Location History:
- Portola Valley, CA (US) (1989 - 2007)
- Menlo Park, CA (US) (2001 - 2012)
Company Filing History:
7 out of 1,062 
1 out of 833,002 Years Active: 1989-2012
Title: Mary Southam: Innovator in Transdermal Drug Delivery Systems
Introduction
Mary Southam is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of drug delivery systems, particularly in the development of transdermal electrotransport devices. With a total of 8 patents to her name, Southam's work has had a profound impact on pain management therapies.
Latest Patents
One of her latest patents is a device for transdermal electrotransport delivery of fentanyl and sufentanil. This invention provides an improved electrotransport drug delivery system for analgesic drugs, specifically fentanyl and sufentanil. The formulation includes a water-soluble salt, such as fentanyl hydrochloride, preferably in a hydrogel formulation, designed for use in an electrotransport device. The transdermal electrotransport delivered dose of fentanyl/sufentanil is sufficient to induce analgesia in adult human patients suffering from moderate-to-severe pain associated with major surgical procedures.
Career Highlights
Throughout her career, Mary Southam has worked with notable companies, including Alza Corporation. Her innovative approaches have led to advancements in the medical field, particularly in pain management solutions.
Collaborations
Some of her coworkers include Keith J Bernstein and Henk Noorduin, who have contributed to her research and development efforts.
Conclusion
Mary Southam's contributions to transdermal drug delivery systems exemplify her dedication to improving patient care through innovation. Her patents and collaborations highlight her role as a leading inventor in the medical technology field.